Clinical Trial Update: Observational Study of Subcutaneous Immunoglobulin (Cutaquig) in Patients With Primary and Secondary Immunodeficiency.

View source ↗

Summary

An observational study evaluating subcutaneous immunoglobulin Cutaquig in patients with primary and secondary immunodeficiency; the trial is currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunodeficiency

Drugs mentioned

• Cutaquig (immunoglobulin G (human) for subcutaneous administration)

Snippet

Sponsor: University of Alberta | Conditions: Primary Immune Deficiency Disorder, Secondary Immune Deficiency | Status: ACTIVE_NOT_RECRUITING